Collaboration and License Agreements - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended
	May 08, 2023	Jul. 31, 2023	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Collaboration And License Agreements [Line Items]
Collaboration and license revenue			$ 3,148	$ 4,056	$ 9,951	$ 7,077
Long-term deferred revenue			7,644		7,644
Amgen Inc. | Amgen Agreement
Collaboration And License Agreements [Line Items]
License agreement date	May 08, 2023
Upfront payment receivable	$ 30,000
Upfront payment	$ 500,000
Expects research term	3 years
Collaboration and license revenue			3,100		3,100
Deferred revenue			26,900		26,900
Long-term deferred revenue			$ 7,600		$ 7,600
Amgen Inc. | Subsequent Event | Amgen Agreement
Collaboration And License Agreements [Line Items]
Upfront payment received		$ 30,000